21. October 2013
New products, new catalogue, new prices! - Transglutaminase newsletter 4-2013

14. October 2013
Press release: Structure of active coagulation factor XIII published

25. September 2013
Structure of active Factor XIII (FXIIIa) published in Angewandte Chemie

22. August 2013
Summer vacation is over - Transglutaminase Newsletter 3-2013

13. May 2013
Isopeptidase App note - Transglutaminase Newsletter 2-2013

11. April 2013
Zedira publication on inhibition of coagulation factor XIIIa from different animal species in Thromb. Res., March 2013

28. March 2013
ZediXclusive Microbial Transglutaminase Assay Kit - Product Information

18. February 2013
tTG detection with increased sensitivity! - Transglutaminase Newsletter 1-2013

01. February 2013
Meet Zedira at the 57th Annual Meeting of Thrombosis and Haemostasis Research (Gesellschaft für Thrombose- und Hämostaseforschung, GTH) in Munich, Germany (February 20th - 23rd 2013). Please contact us via e-mail to make an appointment.

09. January 2013
Zedira co-authors publication on Transglutaminase 6 in Amino Acids, January 2013


  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.


  • Artikel in DLG-Lebensmittel – 06/2017 zur Bestimmung von Transglutaminase in Lebensmitteln (deutsch)
  • Zedira publication: Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated Gliadin
  • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
  • Press Release: Dr. Falk Pharma GmbH and Zedira enter a phase 1b clinical trial for a celiac disease drug
  • Zedira publication: Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope
  • Press release: Additional subsidy funding for clinical development of a celiac disease drug
  • Pressemitteilung: Zusätzliche Fördermittel für die klinische Entwicklung eines Zöliakie-Medikamentes
  • Press Release: Cooperation between Zedira and Cardiff University - Transglutaminase 6 is the focus of new research into ataxia
  • Press Release: Dr. Falk Pharma and Zedira enter phase I clinical trials for a celiac disease drug
  • Press release: Zedira receives further funding to develop Factor XIIIa-blockers for safe anticoagulation



  • 8th Annual World ADC

    26.03.2018 - 28.03.2018
    Berlin, Germany

  • 25th International Fibrinogen & Factor XIII Workshop

    03.06.2018 - 07.06.2018
    Wake Forest University in Winston-Salem, NC (USA)

  • Gordon Research Conference on: Transglutaminases in Human Disease Processes

    16.06.2018 - 17.06.2018
    Les Diablerets, Switzerland